More Immutep Ltd news Immutep LtdASX: IMM New investigator-initiated ph2 trial in Soft Tissue Sarcoma Sep 6, 2022 at 3:41 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
